Vericel (VCEL) Stock Price
$41.23 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
8 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Vericel, AI stock picks, stock alerts and much more.
VCEL AI Stock Analysis
AI stock analysis for VCEL is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Vericel (VCEL) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Vericel (VCEL) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vericel (VCEL), currently trading at $41.23, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VCEL
-
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States.
-
Symbol
VCEL
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
VCEL Alternative Data
Web Traffic
Vericel receives an estimated 5752 monthly visitors to vcel.com.
-
Web Traffic
5752
-
Change from Previous Month
13.3%
-
3 Month Change
18.7%
-
YoY Change
18.7%
News Mentions
Vericel was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Vericel has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Vericel has 891 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.9% over the last month.
-
Twitter Followers
891
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Facebook Engagement
Vericel has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
16,499 are following Vericel on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
16499
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
2.9%
Job Postings
Vericel has an estimated 5 open job postings, which is down -50% over the last month.
-
Job Postings
5
-
Daily Change
28.6%
-
1 Month Change
50%
-
3 Month Change
44.4%
-
YoY Change
44.4%
LinkedIn Employees
According to LinkedIn, Vericel has 390 employees.
-
LinkedIn Employees
390
-
Daily Change
0.3%
-
1 Month Change
0%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Business Outlook
According to employee reviews, the business outlook among employees at Vericel is 55 out of 100 (neutral).
-
Business Outlook
55
-
Change from Previous Month
1.8%
-
3 Month Change
0%
-
YoY Change
0%
VCEL Financials
VCEL Key Metrics
-
Total Revenue
$75.4M
-
Net Income
$19.8M
-
Earnings per Share
$0.4
-
Free cash flow
$8.5M
-
EBITDA
$21.6M
-
EBITDA Ratio
0.286378
-
Total Assets
$432.7M
VCEL 2-year Revenue & Income
VCEL 2-year Free Cash Flow
VCEL Technicals
VCEL SMA
VCEL RSI
FAQ
What's the current price of Vericel (VCEL) Stock?
The price of an Vericel (VCEL) share is $41.23.
What's the market cap of Vericel?
The current market cap of Vericel is 2.1B.
Should I buy or sell VCEL?
Vericel shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Vericel is better viewed as a hold or accumulate position while waiting for further developments.
Is Vericel a good investment?
The current analysis of Vericel's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Vericel's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Vericel (VCEL) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Vericel stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Vericel (VCEL) that investors often compare it to?
Vericel (VCEL) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Vericel's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vericel's stock price to be around $41.83 in 2026. Starting from the current price of $41.23, this represents a 1.5% change in price, indicating a neutral outlook for the stock.
How to buy Vericel (VCEL) Stock?
Vericel stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vericel shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.